Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma

被引:0
|
作者
Bolag Altan
Kyoichi Kaira
Akira Watanabe
Norio Kubo
Pinjie Bao
Gantumur Dolgormaa
Erkhem-Ochir Bilguun
Kenichiro Araki
Yoshikatsu Kanai
Takehiko Yokobori
Tetsunari Oyama
Masahiko Nishiyama
Hiroyuki Kuwano
Ken Shirabe
机构
[1] Gunma University Graduate School of Medicine,Department of Oncology Clinical Development
[2] Gunma University Graduate School of Medicine,Department of Hepatobiliary and Pancreatic Surgery
[3] Gunma University Graduate School of Medicine,Department of General Surgical Science
[4] Gunma University Graduate School of Medicine,Department of Molecular Pharmacology and Oncology
[5] Osaka University,Department of Bio
[6] Gunma University Initiative for Advanced Research,system Pharmacology, Graduate School of Medicine
[7] Gunma University Graduate School of Medicine,Division of Integrated Oncology Research, Research Program for Omics
来源
关键词
LAT1; Pancreatic cancer; Prognosis; Chemotherapy; Resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:141 / 153
页数:12
相关论文
共 50 条
  • [1] Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma
    Jie Weng
    Mengyun Tu
    Bo Yang
    Zhiyi Wang
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 367 - 367
  • [2] Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma
    Weng, Jie
    Tu, Mengyun
    Yang, Bo
    Wang, Zhiyi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 367 - 367
  • [3] Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma
    Altan, Bolag
    Kaira, Kyoichi
    Watanabe, Akira
    Kubo, Norio
    Bao, Pinjie
    Dolgormaa, Gantumur
    Bilguun, Erkhem-Ochir
    Araki, Kenichiro
    Kanai, Yoshikatsu
    Yokobori, Takehiko
    Oyama, Tetsunari
    Nishiyama, Masahiko
    Kuwano, Hiroyuki
    Shirabe, Ken
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 141 - 153
  • [4] Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma
    Kaira, Kyoichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 369 - 369
  • [5] Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma
    Kyoichi Kaira
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 369 - 369
  • [6] Significant relationship between the LAT1 expression pattern and chemoresistance in ovarian clear cell carcinoma
    Kimiya Sato
    Morikazu Miyamoto
    Masashi Takano
    Kenichi Furuya
    Hitoshi Tsuda
    Virchows Archiv, 2019, 474 : 701 - 710
  • [7] LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung
    Kuniaki Nakanishi
    Hirotaka Matsuo
    Yoshikatsu Kanai
    Hitoshi Endou
    Sadayuki Hiroi
    Susumu Tominaga
    Makio Mukai
    Eiji Ikeda
    Yuichi Ozeki
    Shinsuke Aida
    Toshiaki Kawai
    Virchows Archiv, 2006, 448 : 142 - 150
  • [8] Significant relationship between the LAT1 expression pattern and chemoresistance in ovarian clear cell carcinoma
    Sato, Kimiya
    Miyamoto, Morikazu
    Takano, Masashi
    Furuya, Kenichi
    Tsuda, Hitoshi
    VIRCHOWS ARCHIV, 2019, 474 (06) : 701 - 710
  • [9] LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung
    Nakanishi, K
    Matsuo, H
    Kanai, Y
    Endou, H
    Hiroi, S
    Tominaga, S
    Mukai, M
    Ikeda, E
    Ozeki, Y
    Aida, S
    Kawai, T
    VIRCHOWS ARCHIV, 2006, 448 (02) : 142 - 150
  • [10] High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas
    Yanagisawa, Nobuyuki
    Ichinoe, Masaaki
    Mikami, Tetuo
    Nakada, Norihiro
    Hana, Kiyomi
    Koizumi, Wasaburo
    Endou, Hitoshi
    Okayasu, Isao
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (11) : 1019 - 1023